- Home
- AMRX vs ETY Comparison
AMRX vs ETY Comparison
Compare AMRX & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- ETY
- Stock Information
- Founded
- AMRX 2002
- ETY 2006
- Country
- AMRX United States
- ETY United States
- Employees
- AMRX N/A
- ETY N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- AMRX Health Care
- ETY Finance
- Exchange
- AMRX Nasdaq
- ETY Nasdaq
- Market Cap
- AMRX 2.5B
- ETY 2.4B
- IPO Year
- AMRX N/A
- ETY N/A
- Fundamental
- Price
- AMRX $9.39
- ETY $15.89
- Analyst Decision
- AMRX Strong Buy
- ETY
- Analyst Count
- AMRX 4
- ETY 0
- Target Price
- AMRX $11.50
- ETY N/A
- AVG Volume (30 Days)
- AMRX 1.5M
- ETY 247.3K
- Earning Date
- AMRX 08-05-2025
- ETY 01-01-0001
- Dividend Yield
- AMRX N/A
- ETY 7.21%
- EPS Growth
- AMRX N/A
- ETY N/A
- EPS
- AMRX 0.01
- ETY N/A
- Revenue
- AMRX $2,852,914,000.00
- ETY N/A
- Revenue This Year
- AMRX $9.92
- ETY N/A
- Revenue Next Year
- AMRX $7.39
- ETY N/A
- P/E Ratio
- AMRX $853.53
- ETY N/A
- Revenue Growth
- AMRX 9.81
- ETY N/A
- 52 Week Low
- AMRX $6.69
- ETY $10.59
- 52 Week High
- AMRX $9.48
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- AMRX 77.19
- ETY 61.39
- Support Level
- AMRX $7.98
- ETY $15.72
- Resistance Level
- AMRX $8.57
- ETY $15.97
- Average True Range (ATR)
- AMRX 0.27
- ETY 0.19
- MACD
- AMRX 0.15
- ETY 0.01
- Stochastic Oscillator
- AMRX 98.85
- ETY 90.80
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.